Feldan Therapeutics Stock

Feldan Therapeutics has developed a patented peptide-based technology platform.

Sign up today and learn more about Feldan Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Feldan Therapeutics Stock

Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of the unique characteristics of the Shuttle.

Funding History

September 2018$13.8M
October 2018$2.0M
June 2023$16.5M

Management

Board Member

Robert Wills

Chief Executive Officer & Co-Founder

Francois-Thomas Michaud

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo